| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8526366 | Biomedicine & Pharmacotherapy | 2018 | 7 Pages |
Abstract
miR-200c repressed HBV replication by directly targeting NFIA, which might provide a novel therapeutic target for HBV infection.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Hui Tian, Zhenkun He,